Antispasmodic effect of botulinum toxin type a on spastic hemiplegia due to cerebrovascular accident

Archives of Iranian Medicine

Volumn 6, Issue 4, 2003, Pages 265-268

  Najafi, Mohammad Reza ^a,b   Rashidi, Iraj ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Botulinum toxins; Cerebrovascular accident; Hemiplegia; Spasticity

Indexed keywords

BOTULINUM ANTISERUM; BOTULINUM TOXIN A; SPASMOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BICEPS BRACHII MUSCLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DEVICE; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERANCE; ELBOW; FEMALE; FLEXOR MUSCLE; HEMIPLEGIA; HUMAN; INFORMED CONSENT; IRAN; JOINT MOBILITY; MALE; MUSCLE WEAKNESS; PATIENT SATISFACTION; RANK SUM TEST; SIDE EFFECT; SKIN MANIFESTATION; SPASTICITY; STROKE; UNIVERSITY HOSPITAL; WRIST;

EID: 1342291071     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gowland C. Management of hemiplegic upper limb. In: Brandstater ME, Baomajian JV, eds. Stroke Rehabilitation. Baltimore: Williams and Wilkins; 1987: 217-45.
2. Wade DT, Wood VA, Hewer RL. Recovery after stroke - the first three months. J Neurol Neurosurg Psychiatry. 1985; 48: 7-13.
3. Mizrahi EM, Angel RW. Impairment of voluntary movement by spasticity. Ann Neurol. 1979; 5: 594-5.
4. Katak PH, Cole AM, Poulos CJ, et al. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized, double-blind study. Arch Phys Med Rehabil. 1992; 73: 4-9.
5. Hesse S, Reiter F, Konrad M, et al. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998; 12: 381-8.
6. Simpson DM, Alexander DN, O'Brien CF, et al. Btulinum toxin type A in the treatment of upper limb extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996; 46: 1306-10.
7. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987; 67: 206-7.
8. Wong V. Use of botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatr Neruol. 1998; 18: 124-31.
9. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J. 1989; 65: 208-10.
10. Watanabe Y, Bakheit AM, McLellan DL. A Study of the effectiveness of botulinum toxin A (Dysport) in the management of muscle spasticity. Disabil Rehabil. 1998; 20: 62-5.
11. Bakheit AM, Thilmann AF, Ward AB, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke. 2000; 31: 2402-6.
12. Hesse S, Lucke D, Malezi C, et al. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehabil Sci. 1992; 5: 98-101.
13. Viriyavejakul A, Vachalathiti R, Poungvarin N. Botulinum treatment for post-stroke spasticity: low dose regime. J Med Assoc Thai. 1998; 81: 413-22.
14. Hesse S, Reiter F, Konrad M, et al. Botulinium toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998; 12: 381-8.